Massachusetts Financial Services’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.49M | Sell |
249,664
-8,426
| -3% | -$219K | ﹤0.01% | 700 |
|
|
2025
Q1 | $6.32M | Buy |
258,090
+933
| +0.4% | +$22.8K | ﹤0.01% | 685 |
|
|
2024
Q4 | $7.38M | Sell |
257,157
-22,788
| -8% | -$654K | ﹤0.01% | 665 |
|
|
2024
Q3 | $10.6M | Buy |
279,945
+13,158
| +5% | +$496K | ﹤0.01% | 636 |
|
|
2024
Q2 | $8.42M | Buy |
266,787
+6,899
| +3% | +$218K | ﹤0.01% | 654 |
|
|
2024
Q1 | $11.4M | Buy |
+259,888
| New | +$11.4M | ﹤0.01% | 614 |
|